Sources of Safety Data and Statistical Strategies for Design and Analysis: Real World Insights-Reference-Cited by-同舟云学术

Sources of Safety Data and Statistical Strategies for Design and Analysis: Real World Insights

Published:2018-03 Issue:2 Volume:52 Page:170-186
ISSN:2168-4790
Container-title:Therapeutic Innovation & Regulatory Science
language:en
Short-container-title:Ther Innov Regul Sci

Author:

Marchenko Olga,Russek-Cohen Estelle,Levenson Mark,Zink Richard C.,Krukas-Hampel Michelle R.,Jiang Qi

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1177/2168479017739270.pdf

Reference88 articles.

1. FDA draft guidance: use of real-world evidence to support regulatory decision-making for medical devices. CDRH. https://www.fda.gov/downloads/medicaldevices/deviceregulationandguidance/guidancedocuments/ucm513027.pdf. Published 2016. Accessed April 23, 2017.

2. 21st Century Cures. https://energycommerce.house.gov/cures. Accessed April 23, 2017.

3. Pletcher MJ, Lo B, Grady D. Informed consent in randomized quality improvement trials: a critical barrier for learning health systems. JAMA Int Med. 2014;174:668–670.

4. Kass N, Faden R, Tunis S. Addressing low risk comparative effectiveness research in proposed changes to US federal regulations governing research. JAMA. 2012;307:1589–1590.

5. McKinney RE, Beskow LM, Ford DE, et al. Use of altered informed consent in pragmatic clinical research. Clin Trials. 2015;12:494–502.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artificial Intelligence in Medical Affairs: A New Paradigm with Novel Opportunities;Pharmaceutical Medicine;2024-09-11

2. An Unsupervised Error Detection Methodology for Detecting Mislabels in Healthcare Analytics;Bioengineering;2024-07-31

3. Using real-world evidence in haematology;Best Practice & Research Clinical Haematology;2024-03

4. Development of a Framework Structuring Themes in the Course of Adverse Drug Reactions from a Patient’s Perspective;Drug Safety;2023-08-31

5. Nebulized corticosteroids versus systemic corticosteroids for patients with acute exacerbation of chronic obstructive pulmonary disease: A systematic review and meta-analysis comparing the benefits and harms reported by observational studies and randomized controlled trials;Frontiers in Pharmacology;2022-10-05